UK Tax Perks Lure £500m GSK Investment
This article was originally published in The Pink Sheet Daily
Executive Summary
GSK responds to proposed U.K. tax changes by investing £500 million in manufacturing and setting up a U.K.-targeted venture capital fund
You may also be interested in...
GSK Applauds U.K.'s Tax Changes, Announces New Jobs And Manufacturing Facilities
GlaxoSmithKline is to invest £500 million in new U.K. manufacturing facilities in Ulverston, Montrose and Irvine, creating 1,000 jobs in the process.
Proposed U.K. Budget Boost To Benefit Drug Industry
Amid drastic cuts in public-sector spending, the new U.K. government wants tax and regulatory changes to improve the environment for Big Pharma and biotech.
Proposed U.K. Budget Boost To Benefit Drug Industry
Amid drastic cuts in public-sector spending, the new U.K. government wants tax and regulatory changes to improve the environment for Big Pharma and biotech.